BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 19018081)

  • 1. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
    Hensley ML; Hagerty KL; Kewalramani T; Green DM; Meropol NJ; Wasserman TH; Cohen GI; Emami B; Gradishar WJ; Mitchell RB; Thigpen JT; Trotti A; von Hoff D; Schuchter LM
    J Clin Oncol; 2009 Jan; 27(1):127-45. PubMed ID: 19018081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
    Hensley ML; Schuchter LM; Lindley C; Meropol NJ; Cohen GI; Broder G; Gradishar WJ; Green DM; Langdon RJ; Mitchell RB; Negrin R; Szatrowski TP; Thigpen JT; Von Hoff D; Wasserman TH; Winer EP; Pfister DG
    J Clin Oncol; 1999 Oct; 17(10):3333-55. PubMed ID: 10506637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
    Schuchter LM; Hensley ML; Meropol NJ; Winer EP;
    J Clin Oncol; 2002 Jun; 20(12):2895-903. PubMed ID: 12065567
    [No Abstract]   [Full Text] [Related]  

  • 4. New strategies for management of oral mucositis in cancer patients.
    Peterson DE
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
    McDonnell AM; Lenz KL
    Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials.
    Capizzi RL; Oster W
    Int J Hematol; 2000 Dec; 72(4):425-35. PubMed ID: 11197208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of amifostine: from cytoprotectant to therapeutic agent.
    Santini V; Giles FJ
    Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprotection in anticancer therapy: the emerging role of amifostine (WR-2721).
    Kurbacher CM; Mallmann PK
    Anticancer Res; 1998; 18(3C):2203-10. PubMed ID: 9703784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
    Radtke ML; Kolesar JM
    J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of cancer chemotherapy. Cytoprotective agents].
    Lopez M
    Clin Ter; 2001; 152(2):135-43. PubMed ID: 11441524
    [No Abstract]   [Full Text] [Related]  

  • 11. Future development of amifostine in cancer treatment.
    Alberts DS; Bleyer WA
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):90-9. PubMed ID: 8783674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoprotective agents used in the treatment of patients with cancer.
    Hogle WP
    Semin Oncol Nurs; 2007 Aug; 23(3):213-24. PubMed ID: 17693348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing oral mucositis in patients with hematologic malignancies.
    J Support Oncol; 2006 Feb; 4(2):79. PubMed ID: 16499126
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.
    Rubenstein EB; Peterson DE; Schubert M; Keefe D; McGuire D; Epstein J; Elting LS; Fox PC; Cooksley C; Sonis ST; ;
    Cancer; 2004 May; 100(9 Suppl):2026-46. PubMed ID: 15108223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.
    Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amifostine and radiation therapy: past, present, and future.
    Tannehill SP; Mehta MP
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):69-77. PubMed ID: 8783671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy.
    Links M; Lewis C
    Drugs; 1999 Mar; 57(3):293-308. PubMed ID: 10193684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amifostine and chemotherapy-related thrombocytopenia.
    Budd GT
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):49-52. PubMed ID: 8783667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current role of chemotherapy protectors in cancer treatment.
    Cáceres W; Báez L; Aponte I; Rodríguez N; Maldonado A
    Bol Asoc Med P R; 1997; 89(10-12):184-8. PubMed ID: 9577052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated clinical practice guidelines for the prevention and treatment of mucositis.
    Keefe DM; Schubert MM; Elting LS; Sonis ST; Epstein JB; Raber-Durlacher JE; Migliorati CA; McGuire DB; Hutchins RD; Peterson DE;
    Cancer; 2007 Mar; 109(5):820-31. PubMed ID: 17236223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.